Both Insulin glargine and Trazodone offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Insulin glargine and Trazodone have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Trazodone has a more stable therapeutic effect and is less likely to lead to dependency or cravings compared to Insulin glargine.

Trazodone offers greater flexibility with different delivery forms, making it suitable for patients with specific preferences or medical needs.

Both Insulin glargine and Trazodone have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Insulin glargine is great for fast relief, while Trazodone is better for long-term management. The choice depends on the patient’s specific needs.